Vice President, Marketing

Lead global commercial strategy for KT-621 from late-stage development through launch and lifecycle management. Define the global product vision, positioning, differentiation, target patient segments, and value proposition; lead U.S. launch readiness planning and all commercialization activities; develop disease-state and product-specific marketing strategies and messaging; partner with Analytics & Insights on competitive intelligence, market assessments, forecasting inputs, and customer research; serve as the commercial lead within cross-functional development teams; influence clinical development strategy, endpoint selection, and evidence-generation plans; evaluate expansion opportunities across immunology indications; build strong partnerships across Clinical Development, Medical Affairs, Market Access, Regulatory, Finance, and Executive Leadership; demonstrate strategic thinking, executive communication, and leadership to drive successful commercialization of KT-621 in immunology indications including atopic dermatitis and asthma.